Results 201 to 210 of about 43,902 (289)

Efficacy and safety of denosumab in treatment of osteoporosis in patients with rheumatoid arthritis: a meta-analysis and systematic review. [PDF]

BMC Musculoskelet Disord
Zhang R, Kou N, Liu F, Zhou H, Ren L.
europepmc   +1 more source

Transient increase in skeletal-related events after discontinuation of high-dose denosumab in cancer patients. [PDF]

J Bone Oncol
Setsu N, Yokoyama N, Esaki T, Yamaguchi M, Tokunaga E, Negishi T.   +5 more
europepmc   +1 more source

Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS) [PDF]

Ruibo Li, Xingyue Yuan, Xi Chen, Yili Ou, Jin Chen   +4 more
openalex   +1 more source

Effectiveness and safety of denosumab monotherapy in patients with primary hyperparathyroidism: A retrospective study. [PDF]

Medicine (Baltimore)
Okada A, Baba R, Ishibashi Y, Otagaki Y, Kodama T, Egusa G, Nagano G, Matsuda T, Hattori N, Ohno H.   +9 more
europepmc   +1 more source

What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia [PDF]

, 2016
Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji, Sofoora Kawsar Usman   +3 more
openalex   +1 more source

Long-Term Management of Breast Cancer Bone Metastases: Two Case Reports. [PDF]

Int J Breast Cancer
Lin X, Zeng R.
europepmc   +1 more source

Efficacy and safety of denosumab for osteoporosis in patients with autoimmune liver diseases

, 2017
Yoshitaka Arase, Tatehiro Kagawa, Kota Tsuruya, Kazuya Anzai, Shunji Hirose, Koichi Shiraishi, Tetsuya Mine   +6 more
openalex   +2 more sources

Denosumab improves bone mineral density, promotes fracture healing, and reduces recurrent fractures in patients with osteoporotic fractures. [PDF]

Am J Transl Res
Liang S, Jiang P, Yang D, Huo Y, Zhao G, Bai Y.   +5 more
europepmc   +1 more source

FRI0551 Use of glucocorticoid is the risk factor for inadequate response to the treatment of osteoporosis by denosumab [PDF]

, 2017
Kumi Orita, Tatsuya Koike
openalex   +1 more source

Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial. [PDF]

Hepatol Commun
Arase Y, Okubo T, Arai T, Abe M, Namisaki T, Uojima H, Matsumoto K, Kakisaka K, Kakisaka K, Setsu T, Mishima Y, Tsuruya K, Hirose S, Deguchi R, Shiraishi K, Atsukawa M, Ikegami T, Honda A, Terai S, Yoshiji H, Komori A, Tanaka A, Kagawa T.   +22 more
europepmc   +1 more source